NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

CUSIP: 639027101

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class
Equity / Common Stock
Total 13F shares
14,481,961
Total 13F value
$224,745,599
Holder snapshot 6 signals
Share change
+179,066
SEC-reported price per share
$15.52
Number of holders
121
Value change
+$3,447,179
Number of buys
77
Number of sells
32
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
17,654,067

Security key

639027101

Report period

Q3 2025

Institutions

121

Top holders

10

NATR full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 NATURES SUNSHINE PRODUCTS INC SEC filings NATURES SUNSHINE PRODUCTS INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NATR - NATURES SUNSHINE PRODUCTS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DIMENSIONAL FUND ADVISORS LP
Disclosed value leader
WYNNEFIELD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 5.2% 13D/G row: DIMENSIONAL FUND ADVISORS LP Showing 1-6 of 15 holder rows.

Quick read

DIMENSIONAL FUND ADVISORS LP leads the comparable SEC ownership view at 5.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DIMENSIONAL FUND ADVISORS LP's linked filing trail.
Comparable ownership Top 5
DIMENSIONAL FUND ADVISORS LP 5.2%
BlackRock, Inc. 5%
Shanghai Fosun Pharmaceutical (Gr... 0.35%
Fosun Pharma USA Inc. 16%
PRESCOTT GROUP CAPITAL MANAGEMENT... 10%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DIMENSIONAL FUND ADVISORS LP
13D/G 13F
Company
13D/G 13F
5.2%
$14,181,854
913,791 shares
 $0 30 Sep 2025
BlackRock, Inc.
13F 13D/G
Company
13F 13D/G
5%
from 13D/G
$14,016,587
947,707 shares
 — 30 Jun 2025
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
13D/G 3/4/5
10%+ Owner
13D/G 3/4/5
0.35%
$735,354
64,167 shares
 -$32,713,796 25 Jun 2025
Fosun Pharma USA Inc.
3/4/5
10%+ Owner
3/4/5
16%
$32,713,796
2,854,607 shares
 — 05 Jun 2025
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
10%
$28,226,425
1,783,097 shares
 — 31 Jul 2025
Terrence Moorehead
3/4/5
Chief Executive Officer, Director
3/4/5
3.1%
$8,040,721
543,292 shares
 — 21 Jul 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
121
Shares
14,481,961
Rows available
121
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q1 2026 Across Filers

Q1 2026 holders
152
Q3 2025 holders
121
Holder diff
-31
Investor Q1 2026 Shares Q3 2025 Shares Share Diff Share Chg % Q1 2026 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .